Product Information

CEFDINIR 250 MG/5 ML SUSP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1189 per ML under NDC 00093413764. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on May 4, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CEFDINIR 250 MG/5 ML SUSP

Cefdinir
$0.1189per ML

Strength

250 mg/5mL

NDC

00093413764

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CEFDINIR MONOHYDRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA065332

FDA Approved

5/4/2007

TE Code

AB

On Market Since

5/8/2007

Pharmacological Classes

Price Statistics

The NADAC for CEFDINIR 250 MG/5 ML SUSP has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 83.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1189 per ML
All-time high$0.7852 (Feb 12, 2014)
All-time low$0.1148 (Nov 20, 2024)
52-week high$0.1301
52-week low$0.1176
Median price$0.1751
Average price$0.2743
Largest weekly change+39.7% (Feb 1, 2023)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+1.1%

3M

-3.5%

6M

-4.8%

1Y

-11.0%

3Y

-30.2%

5Y

-23.6%

All

-83.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CEFDINIR 250 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for CEFDINIR 250 MG/5 ML SUSP, manufactured by Teva Pharmaceuticals USA Inc., is $0.1189 per ML (NDC 00093413764), effective Nov 11, 2026.

How has the price of CEFDINIR 250 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for CEFDINIR 250 MG/5 ML SUSP has declined 83.9%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CEFDINIR 250 MG/5 ML SUSP?

Since Nov 28, 2013, the NADAC for CEFDINIR 250 MG/5 ML SUSP has ranged from a low of $0.1148 (Nov 20, 2024) to a high of $0.7852 (Feb 12, 2014), with a median of $0.1751 per ML.

Are there cheaper alternatives to CEFDINIR 250 MG/5 ML SUSP?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFDINIR 250 MG/5 ML SUSP, is $0.1106 per ML — about 7% below CEFDINIR 250 MG/5 ML SUSP.

Who manufactures CEFDINIR 250 MG/5 ML SUSP?

CEFDINIR 250 MG/5 ML SUSP (NDC 00093413764) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.